The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Comparing HIV‐1 and HIV‐2 infection: Lessons for viral immunopathogenesis
Abstract
SUMMARY: HIV‐1 and HIV‐2 share many similarities including their basic gene arrangement, modes of transmission, intracellular replication pathways and clinical consequences: both result in AIDS. However, HIV‐2 is characterised by lower transmissibility and reduced likelihood of progression to AIDS. The underlying mechanistic differences between these two infections illuminate broader issues of retroviral pathogenesis, which remain incompletely understood. Comparisons between these two infections from epidemiological, clinical, virologic and immunologic viewpoints provide a basis for hypothesis generation and testing in this ‘natural experiment’ in viral pathogenesis. In terms of epidemiology, HIV‐2 remains largely confined to West Africa, whereas HIV‐1 extends worldwide. Clinically, HIV‐2 infected individuals seem to dichotomise, most remaining long‐term non‐progressors, whereas most HIV‐1 infected individuals progress. When clinical progression occurs, both diseases demonstrate very similar pathological processes, although progression in HIV‐2 occurs at higher CD4 counts. Plasma viral loads are consistently lower in HIV‐2, as are average levels of immune activation. Significant differences exist between the two infections in all components of the immune system. For example, cellular responses to HIV‐2 tend to be more polyfunctional and produce more IL‐2; humoral responses appear broader with lower magnitude intratype neutralisation responses; innate responses appear more robust, possibly through differential effects of tripartite motif protein isoform 5 alpha. Overall, the immune response to HIV‐2 appears more protective against disease progression suggesting that pivotal immune factors limit viral pathology. If such immune responses could be replicated or induced in HIV‐1 infected patients, they might extend survival and reduce requirements for antiretroviral therapy. Copyright © 2013 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Origins of HIV and the AIDS Pandemic
Sharp, P. M., & Hahn, B. H. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006841 · Cited by 1,496
Isolation of a New Human Retrovirus from West African Patients with AIDS
Clavel, F., Guétard, D., Brun-Vézinet, F., Chamaret, S., Rey, M.-A., Santos-Ferreira, M. O., Laurent, A. G., Dauguet, C., Katlama, C., Rouzioux, C., et al. (1986) · Science · doi:10.1126/science.2425430 · Cited by 1,306
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200 · cited 5×
“The effect of SAMHD1 onHIV-1 strains is therefore to restrict their replication in dendritic and myeloid cells; HIV-2 strains, by contrast, escape such restriction because they possess Vpx [88,89].”
BackgroundInfluentialCao, Y., Qin, L., Zhang, L., Safrit, J., & Ho, D. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501263320401 · Cited by 1,037
Giorgi, J. V., Hultin, L. E., McKeating, J. A., Johnson, T. D., Owens, B., Jacobson, L. P., Shih, R., Lewis, J., Wiley, D. J., Phair, J. P., et al. (1999) · The Journal of Infectious Diseases · doi:10.1086/314660 · Cited by 1,033
Genome organization and transactivation of the human immunodeficiency virus type 2
Guyader, M., Emerman, M., Sonigo, P., Clavel, F., Montagnier, L., & Alizon, M. (1987) · Nature · doi:10.1038/326662a0 · Cited by 848
Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans
Hellerstein, M., Hanley, M. B., Cesar, D., Siler, S., Papageorgopoulos, C., Wieder, E., Schmidt, D., Hoh, R., Neese, R., Macallan, D., et al. (1999) · Nature Medicine · doi:10.1038/4772 · Cited by 593
Self-citationThe mortality and pathology of HIV infection in a West African city
Lucas, S. B., Hounnou, A., Peacock, C., Beaumel, A., Djomand, G., NʼGbichi, J.-M., Yeboue, K., Hondé, M., Diomande, M., Giordano, C., et al. (1993) · AIDS · doi:10.1097/00002030-199312000-00005 · Cited by 562
A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells
Manel, N., Hogstad, B., Wang, Y., Levy, D. E., Unutmaz, D., & Littman, D. R. (2010) · Nature · doi:10.1038/nature09337 · Cited by 427
Species-Specific Activity of SIV Nef and HIV-1 Vpu in Overcoming Restriction by Tetherin/BST2
Jia, B., Serra-Moreno, R., Neidermyer, W., Rahmberg, A., Mackey, J., Fofana, I. B., Johnson, W. E., Westmoreland, S., & Evans, D. T. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000429 · Cited by 406
Albert, J., Abrahamsson, B., Nagy, K., Aurelius, E., Gaines, H., Nyström, G., & Fenyö, E. M. (1990) · AIDS · doi:10.1097/00002030-199002000-00002 · Cited by 398
Increased Turnover of T Lymphocytes in HIV-1 Infection and Its Reduction by Antiretroviral Therapy
Mohri, H., Perelson, A. S., Tung, K., Ribeiro, R. M., Ramratnam, B., Markowitz, M., Kost, R., Hurley, Weinberger, L., Cesar, D., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1277 · Cited by 358
Pilgrim, A. K., Pantaleo, G., Cohen, O. J., Fink, L. M., Zhou, J. Y., Zhou, J. T., Bolognesi, D. P., Fauci, A. S., & Montefiori, D. C. (1997) · The Journal of Infectious Diseases · doi:10.1086/516508 · Cited by 326
Le Tortorec, A., & Neil, S. J. D. (2009) · Journal of Virology · doi:10.1128/jvi.01515-09 · Cited by 280
Polyfunctional T cell responses are a hallmark of HIV‐2 infection
Duvall, M. G., Precopio, M. L., Ambrozak, D. A., Jaye, A., McMichael, A. J., Whittle, H. C., Roederer, M., Rowland‐Jones, S. L., & Koup, R. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200737768 · Cited by 243
Self-citationAriën, K. K., Abraha, A., Quiñones-Mateu, M. E., Kestens, L., Vanham, G., & Arts, E. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8979-8990.2005 · Cited by 223
Population migration and the spread of types 1 and 2 human immunodeficiency viruses.
Quinn, T. C. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2407 · Cited by 208
BIOMEDICINE:The Enigmas of Kaposi's Sarcoma
Gallo, R. C. (1998) · Science · doi:10.1126/science.282.5395.1837 · Cited by 198
Ahn, J., Hao, C., Yan, J., DeLucia, M., Mehrens, J., Wang, C., Gronenborn, A. M., & Skowronski, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.340711 · Cited by 184
O'Donovan, D., Ariyoshi, K., Milligan, P., Ota, M., Yamuah, L., Sarge-Njie, R., & Whittle, H. (2000) · AIDS · doi:10.1097/00002030-200003100-00019 · Cited by 163
Popper, S. J., Sarr, A. D., Guèye‐Ndiaye, A., Mboup, S., Essex, M., & Kanki, P. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.3.1554-1557.2000 · Cited by 151
Ylinen, L. M. J., Keckesova, Z., Wilson, S. J., Ranasinghe, S., & Towers, G. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.18.11580-11587.2005 · Cited by 151
9-year HIV-2-associated mortality in an urban community in Bissau, west Africa
Poulsen, A., Aaby, P., Larsen, O., Jensen, H. E., Nauclér, A., Lisse, I. M., Christiansen, C. B., Dias, F., & Melbye, M. (1997) · The Lancet · doi:10.1016/s0140-6736(96)04402-9 · Cited by 147
Cytokines and Growth Factors in the Pathogenesis of AIDS‐Associated Kaposi's Sarcoma
Ensoli, B., Barillari, G., & Gallo, R. C. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01412.x · Cited by 144
Nakayama, E. E., Miyoshi, H., Nagai, Y., & Shioda, T. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8870-8877.2005 · Cited by 125
Soriano, V., Gómes, P., Heneine, W., Holgu�n, A., Doruana, M., Antunes, R., Mansinho, K., Switzer, W. M., Araújo, C., Shanmugam, V., et al. (2000) · Journal of Medical Virology · Cited by 124
Microbial Translocation Correlates with the Severity of Both HIV‐1 and HIV‐2 Infections
Nowroozalizadeh, S., Månsson, F., da Silva, Z. J., Repits, J., Dabo, B., Pereira, C. C., Biague, A. J., Albert, J., Nielsen, J. O., Aaby, P., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/651430 · Cited by 117
Inhibition of HIV-1 Disease Progression by Contemporaneous HIV-2 Infection
Esbjörnsson, J., Månsson, F., Kvist, A., Isberg, P., Nowroozalizadeh, S., Biague, A. J., da Silva, Z. J., Jansson, M., Fenyõ, É. M., Norrgren, H., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113244 · Cited by 112
van der Loeff, M. F. S., Jaffar, S. S., Aveika, A. A., Sabally, S., Corrah, T., Harding, E., Alabi, A. S., Bayang, A., Ariyoshi, K., & Whittle, H. C. (2002) · AIDS · doi:10.1097/00002030-200209060-00010 · Cited by 111
Maintenance of HIV-Specific CD4+ T Cell Help Distinguishes HIV-2 from HIV-1 Infection
Duvall, M. G., Jaye, A., Dong, T., Brenchley, J. M., Alabi, A. S., Jeffries, D. J., van der Sande, M. A. B., Togun, T. O., McConkey, S. J., Douek, D. C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6973 · Cited by 109
Self-citationvan der Loeff, M. F. S., Awasana, A. A., Sarge‐Njie, R., van der Sande, M. A. B., Jaye, A., Sabally, S., Corrah, T., McConkey, S. J., & Whittle, H. C. (2006) · International Journal of Epidemiology · doi:10.1093/ije/dyl037 · Cited by 103
Self-citationLow Level Viremia and High CD4% Predict Normal Survival in a Cohort of HIV Type-2-Infected Villagers
Berry, N. J., Jaffar, S. S., van der Loeff, M. F. S., Ariyoshi, K., Harding, E., N’Gom, P. T., Dias, F., Wilkins, A., Ricard, D., Aaby, P., et al. (2002) · AIDS Research and Human Retroviruses · doi:10.1089/08892220260387904 · Cited by 85
Gottlieb, G. S., Hawes, S. E., Agne, H. D., Stern, J., Critchlow, C. W., Kiviat, N. B., & Sow, P. S. (2006) · AIDS · doi:10.1097/01.aids.0000218554.59531.80 · Cited by 85
Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection
Leligdowicz, A., Yindom, L. ‐., Onyango, C. O., Sarge‐Njie, R., Alabi, A. S., Cotten, M. L., Vincent, T., Costa, C. D. S., Aaby, P., Jaye, A., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci32380 · Cited by 84
Self-citationTwenty Years of Prospective Molecular Epidemiology in Senegal: Changes in HIV Diversity
Hamel, D. J., Sankalé, J.-L., Eisen, G., Meloni, S., Mullins, C., Guèye‐Ndiaye, A., Mboup, S., & Kanki, P. J. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2007.0037 · Cited by 77
van Tienen, C., van der Loeff, M. F. S., Zaman, S. M. A., Vincent, T., Sarge‐Njie, R., Peterson, I., Leligdowicz, A., Jaye, A., Rowland‐Jones, S., Aaby, P., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181bf1a25 · Cited by 70
Self-citationSchramm, B., Penn, M. L., Palacios, E. H., Grant, R. M., Kirchhoff, F., & Goldsmith, M. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.20.9594-9600.2000 · Cited by 70
van der Loeff, M. F. S., Sarge‐Njie, R., Ceesay, S., Awasana, A. A., Jaye, P., Sam, O., Jaiteh, K. O., Cubitt, D. W., Milligan, P. J., & Whittle, H. C. (2003) · AIDS · doi:10.1097/00002030-200308150-00014 · Cited by 70
van der Loeff, M. F. S., Sarge‐Njie, R., Ceesay, S., Awasana, A. A., Jaye, P., Sam, O., Jaiteh, K. O., Cubitt, D. W., Milligan, P. J., & Whittle, H. C. (2003) · PubMed · doi:10.1097/01.aids.0000076303.76477.49 · Cited by 67
Broad and Potent Neutralizing Antibody Responses Elicited in Natural HIV-2 Infection
Kong, R., Li, H., Bibollet‐Ruche, F., Decker, J. M., Zheng, N. N., Gottlieb, G. S., Kiviat, N. B., Sow, P. S., Georgiev, I. S., Hahn, B. H., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06155-11 · Cited by 63
Antiretroviral Therapy for HIV-2 Infection: Recommendations for Management in Low-Resource Settings
Peterson, K., Jallow, S., Rowland‐Jones, S., & de Silva, T. I. (2011) · AIDS Research and Treatment · doi:10.1155/2011/463704 · Cited by 60
Self-citationDirect Relationship between Virus Load and Systemic Immune Activation in HIV‐2 Infection
Leligdowicz, A., Feldmann, J., Jaye, A., Cotten, M. L., Dong, T., McMichael, A. J., Whittle, H. C., & Rowland-Jones, S. L. (2009) · The Journal of Infectious Diseases · doi:10.1086/648733 · Cited by 60
Self-citationSoares, R. S., Rego, R. T., Foxall, R. B., Baptista, A. P., Cavaleiro, R., Gómes, P., Camacho, R. J., Valadas, E., Doroana, M., Lucas, M. B., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01921-10 · Cited by 57
Zheng, N. N., Kiviat, N. B., Sow, P. S., Hawes, S. E., Wilson, A. J., Agne, H. D., Critchlow, C. W., Gottlieb, G. S., Musey, L. K., & McElrath, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13934-13942.2004 · Cited by 55
Willey, S. J., Reeves, J. D., Hudson, R., Miyake, K., Dejucq‐Rainsford, N., Schols, D., Clercq, E. D., Bell, J. E., McKnight, Á., & Clapham, P. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.11.6138-6152.2003 · Cited by 55
de Silva, T. I., Aasa-Chapman, M. M. I., Cotten, M. L., Hué, S., Robinson, J., Bibollet‐Ruche, F., Sarge‐Njie, R., Berry, N. J., Jaye, A., Aaby, P., et al. (2011) · Journal of Virology · doi:10.1128/jvi.06126-11 · Cited by 51
Self-citationDuvall, M. G., Loré, K., Blaak, H., Ambrozak, D. R., Adams, W. C. T., Santos, K., Geldmacher, C., Mascola, J. R., McMichael, A. J., Jaye, A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.00976-07 · Cited by 48
Self-citationSousa, A. E., Chaves, A. F., Loureiro, A. I., & Victorino, R. M. M. (2001) · The Journal of Infectious Diseases · doi:10.1086/322804 · Cited by 48
HIV-2 capsids distinguish high and low virus load patients in a West African community cohort
Onyango, C. O., Leligdowicz, A., Yokoyama, M., Sato, H., Song, H., Nakayama, E. E., Shioda, T., de Silva, T. I., Townend, J., Jaye, A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2009.08.060 · Cited by 47
Self-citationPeterson, I., Togun, O., de Silva, T. I., Oko, F., Rowland‐Jones, S., Jaye, A., & Peterson, K. (2011) · AIDS · doi:10.1097/qad.0b013e32834c4adb · Cited by 42
Self-citationLeligdowicz, A., Onyango, C. O., Yindom, L. ‐., Peng, Y., Cotten, M. L., Jaye, A., McMichael, A. J., Whittle, H. C., Dong, T., & Rowland‐Jones, S. (2010) · European Journal of Immunology · doi:10.1002/eji.200940295 · Cited by 38
Self-citationIn vitro replication capacity of HIV-2 variants from long-term aviremic individuals
Blaak, H., van der Ende, M. E., Boers, P. H. M., Schuitemaker, H., & Osterhaus, A. D. M. E. (2006) · Virology · doi:10.1016/j.virol.2006.05.029 · Cited by 38
Khalid, M., Yu, H., Sauter, D., Usmani, S. M., Schmökel, J., Feldman, J., Gruters, R. A., van der Ende, M. E., Geyer, M., Rowland‐Jones, S., et al. (2012) · Journal of Virology · doi:10.1128/jvi.06856-11 · Cited by 37
Self-citationSurvival of HIV-1 and HIV-2 perinatally infected children in The Gambia
van der Loeff, M. F. S., Hansmann, A., Awasana, A. A., Ota, M. O. C., O’Donovan, D. T., Sarge‐Njie, R., Ariyoshi, K., Milligan, P. J., & Whittle, H. C. (2003) · AIDS · doi:10.1097/00002030-200311070-00015 · Cited by 34
Jaye, A., Sarge‐Njie, R., van der Loeff, M. F. S., Todd, J., Alabi, A. S., Sabally, S., Corrah, T., & Whittle, H. C. (2004) · The Journal of Infectious Diseases · doi:10.1086/381185 · Cited by 31
Self-citationSkar, H., Borrego, P., Wallstrom, T. C., Mild, M., Marcelino, J. M., Barroso, H., Taveira, N., Leitner, T., & Albert, J. (2010) · Journal of Virology · doi:10.1128/jvi.02548-09 · Cited by 30
Gillespie, G. M. A., Pinheiro, S., Sayeid‐Al‐Jamee, M., Alabi, A. S., Kaye, S., Sabally, S., Sarge‐Njie, R., Njai, H. F., Joof, K., Jaye, A., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526007 · Cited by 28
Self-citationEvidence for negative selective pressure in HIV-2 evolution in vivo☆
Barroso, H., & Taveira, N. (2004) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2004.07.008 · Cited by 28
Productive HIV-2 infection in the brain is restricted to macrophages/microglia
Mörner, A., Thomas, J. A., Björling, E., Munson, P., Lucas, S. B., & McKnight, Á. (2003) · AIDS · doi:10.1097/00002030-200307040-00005 · Cited by 28
Nyamweya, S., Townend, J., Zaman, A., Steele, S. J., Jeffries, D. J., Rowland-Jones, S. L., Whittle, H. C., Flanagan, K. L., & Jaye, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044411 · Cited by 26
Self-citationGautier, D., Beq, S., Cortesão, C. S., Sousa, A. E., & Cheynier, R. (2007) · Journal of Virology · doi:10.1128/jvi.01131-07 · Cited by 24
Schaller, T., Goujon, C., & Malim, M. H. (2012) · Science · doi:10.1126/science.1221057 · Cited by 22
Rego, R. T., Foxall, R. B., Baptista, A. P., Pinto, F. R., Soares, R. S., Cavaleiro, R., Valadas, E., Gómes, P., Victorino, R. M. M., & Sousa, A. E. (2012) · AIDS · doi:10.1097/qad.0b013e32835374db · Cited by 20
Nuvor, S. V., Whittle, H. C., Rowland‐Jones, S., & Jaye, A. (2012) · World Journal of AIDS · doi:10.4236/wja.2012.22014 · Cited by 3
Self-citation
Cited by
Selenium, Selenoproteins and Viral Infection
Guillin, O., Vindry, C., Ohlmann, T., & Chavatte, L. (2019) · Nutrients · doi:10.3390/nu11092101 · Cited by 443
Austin, L. A., Mackey, M. A., Dreaden, E. C., & El-Sayed, M. A. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1245-3 · Cited by 427
Metadata
- Authors
- Nyamweya, S., Hegedus, A., Jaye, A., Rowland‐Jones, S., Flanagan, K. L., & Macallan, D. C.
- Venue
- Reviews in Medical Virology
- Publisher
- Wiley
- Published
- 2013-02-26
- Volume
- 23
- Issue
- 4
- Pages
- 221-240
- ISSN
- 1052-9276 (ISSN-L)
- 1099-1654
- OpenAlex
- W1649237445
- Cited by
- 280
- References
- 66
- FWCI
- 6.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.